[1] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版).中华临床感染病杂志,2012,5:321-327.
[2] Wong WS, Chan LY. Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease. J Gastroenterol Hepatol,2009,24: 1179-1186.
[3] Iervasi G, Pingitore A, Landi P, et al.Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation,2003,107: 708-713.
[4] Den Brinker M, Joosten KFM, Visser TJ,et al.Euthyroid sick syndrome in meningococcal sepsis: the impact of peripheral thyroid hormone metabolism and binding proteins. Clin. Endocrinol. Metab. 2005,90: 5613-5620.
[5] Bacci V, Schussler G C, Kaplan TB. The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab, 1982, 54: 1229-1235.
[6] Brent GA, Hershman JM, Braunstein GD,Patients with severe nonthyroidal illness and serum thyrotropin concentrations in the hypothyroid range. Am J Med, 1986,81: 463-466.
[7] Maheshwari A, Thuluvath PJ, Endocrine diseases and the liver. Clin Liver Dis, 2011, 15: 55-67.
[8] Alessandro A, Clodoveo F, Alessandro P, et al. Thyroid disorders in chronic hepatitis C. Am J Med, 2004, 117: 10-13.
[9] Oren R, Sikuler E, Wong F,et al, The effects of hypothyroidism on liver status of cirrhotic patients.J Clin Gastroenterol, 2000, 31: 162-163.
[10] Babb RR. Associations between diseases of the thyroid and the liver. Am J Gastroenterol, 1984, 79: 421-423.
[11] Liangpunsakul S, Chalasani N. Is hypothyroidism a risk factor for non-alcoholic steatohepatitis? J Clin Gastroenterol, 2003, 37: 340-343.
[12] Chung GE, Kim D, Kim W, et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol, 2012, 57:150-156.
[13] Güven K, Kelestimur F, Yücesoy M. Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy. Eur J Med, 1993, 2: 83-85.
[14] Hepner GW, Chopra IJ. Serum thyroid hormone levels in patients with liverdisease. Arch Intern Med,1979, 139: 1117-1120.
[15] Huang MJ,Liaw YF, Clinical associations between thyroid and liver diseases.J Gastroenterol Hepatol, 1995, 10: 344-350.
[16] Burra P,Franklyn JA, Ramsden DB, et al, Severity of alcoholic liver disease and markers of thyroid and steroid status.Postgrad Med J, 1992,68: 804-810.
[17] Becker U, Gluud C, Bennett P. Thyroid hormones and thyroxine-binding globulin in relation to liver function and serum testosterone in men with alcoholic cirrhosis. Acta Med Scand, 1988,224: 367-373.
[18] Israel Y, Walfish P G, Orrego H, et al. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil.Gastroenterology, 1979,76: 116-122.
[19] Hegedus L, Rasmussen N, Ravn V, et al. Independent effects of liver disease and chronic alcoholism on thyroid function and size: the possibility of a toxic effect of alcohol on the thyroid gland. Metabolism, 1988,37: 229-233.
[20] Golding PL, Smith M,Williams R, Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis.Am J Med,1973, 55: 772-782.
[21] Elta GH, Sepersky RA, Goldberg MJ, et al, Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci,1983, 28: 971-975.
[22] Silveira MG,Mendes FD, Diehl NN, et al, Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease. Liver Int, 2009, 29: 1094-1100.
[23] Hassan MM, Kaseb A, Li D, et al. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology, 2009, 49: 1563-1570.
[24] 马玉波, 周雯婷, 徐枫, 等. 1680例甲状腺激素水平测定结果及临床意义分析. 标记免疫分析与临床, 2012, 19: 181-183.
[25] Borzio M, Caldara R, Borzio F, et al. Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism. Gut, 1983,24: 631-636.
[26] Pateron D, Hartmann DJ,Duclos-Vallee JC, et al, Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol, 1993, 17: 417-419.
[27] 赵艳娟, 叶春艳, 宋效丹. 急性乙型肝炎患者血清甲状腺激素水平变化. 临床肝胆病杂志,2011, 27: 161-165.
[28] 李晨, 王慧芬, 闫伟伟. 慢性肝病对血清甲状腺激素水平的影响. 肝脏, 2008, 13: 396-397.
[29] 于志强, 孙佛晓, 张爱英, 等. 肝硬化患者血清甲状腺素水平变化的研究. 当代医学,2008, 14: 76-77.
[30] Meinhold H, Wenzel KW, Schleusener H, Relations between serum levels of TSH, TBG, T4, T3, rT3 and various histologically classified chronic liver diseases. J Endocrinol Invest,1980, 3: 379-383.
[31] Huang YH, Tsai MM, Lin KH.Thyroid hormone dependent regulation of target genes and their physiological significance. Chang Gung Med J, 2008, 31: 325-334.
[32] Mansour-Ghanaei F, Mehrdad M, Mortazavi S, et al, Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage. Ann Hepatol, 2012, 11: 667-671.
[33] Danai A, Alexandra A, Larisa V, et al. Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure.J Hepatol, 2014, 61: 1446-1447.
[34] 郑振光, 苏文芳.重型肝炎患者甲状腺激素测定结果分析. 上海医学检验杂志, 2001, 16: 33-36.
[35] Kostopanagiotou G, Kalimeris K, Mourouzis I, et al. Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences. Endocrine, 2009, 36: 198-204.
[36] Wu Y, You S, Zang H, et al. Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-chronic liver failure. Ann Hepatol, 2015, 14: 218-224.
[37] Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology, 1992, 103: 264-274.
[38] Vogeser M, Fischer G, Jacob K. Quantification of cortisol inactivation in cirrhosis of the liver. Exp Clin Endocrinol Diabetes, 1998, 106: 410-414.
[39] 彭武.垂体前叶功能减退症的研究进展. 医学综述, 2012, 18: 4150-4153.
[40] Nishizawa H, Iguchi G, Murawaki A, et al. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. Eur J Endocrinol, 2012, 167: 280-283.
[41] Takahashi Y, Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. Endocr J, 2012, 59: 955-962.
[42] Ichikawa T,Nakao K,Hamasaki K, et al, Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease. Hepatol Int, 2007, 1: 287-294.
[43] Adams LA,Feldstein A, Lindor KD, et al, Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology, 2004, 39: 909-914.
[44] Van TDH, Gavaler JS, Spero JA, et al. Patterns of hypothalamic-pituitary-gonadal dysfunction in men with liver disease due to differing etiologies. Hepatology, 1981,1: 39-46.
[45] Bannister P, Handley T,Chapman C,et al. Hypogonadism in chronic liver disease: impaired release of luteinising hormone. British Medical Journal, 1986, 293: 1191-1193.
[46] Fede G, Spadaro L, Tomaselli T, et al. Adrenocortical dysfunction in liver disease: a systematic review. Hepatology, 2012,55: 1282-1291.
[47] Velissaris D, Karanikolas M, Kalogeropoulos A, et al. Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy.W J Gastroenterol, 2008, 14: 4190-4195.
[48] Mcdonald J A, Handelsman D J, Dilworth P, et al. Hypothalamic-pituitary adrenal function in end-stage non-alcoholic liver disease. J GastroenterolHepatol, 1993, 8: 247-253.
[49] 钟艳丹, 杨永峰. 肝肾上腺综合征的研究进展. 肝脏,2008, 13: 520-522.
[50] Marik PE, Adrenal-exhaustion syndrome in patients with liver disease. Intensive Care Med, 2006, 32: 275-280.
[51] Jé, chot, Lori A, et al. Effect of liver transplantation on sex-hormone disorders in male patients with alcohol-induced or post-viral hepatitis advanced liver disease. J Hepatol, 1994, 20: 426-430.
[52] Stewart PM,Burra P,Shackleton CH,et al, 11 Beta-hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. J Clin Endocrinol Metab, 1993, 76: 748-751.
[53] Cundy TF, Butler J, Pope RM,et al.Amenorrhoea in women with non-alcoholic chronic liver disease. Gut, 1991, 32: 202-206.
[54] Sorrell JH, Brown JR. Sexual functioning in patients with end-stage liver disease before and after transplantation. Liver Transpl, 2006,12: 1473-1477.
[55] Wiesner RH, McDiarmid SV,Kamath PS,et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl, 2001,7: 567-580.
[56] Burra P. "Sexual dysfunction after liver transplantation." transplantation. Liver Transpl, 2009, 15: S50-S56
[57] Burra P, Germani GA,De ME, et al, Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure? Transplantation,2010, 89: 1425-1429.
[58] Helsman DJ, Simone S, Mcdonald JA, et al. Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation. Clin Endocrinol, 1995, 43:331-337.
[59] Naparstek Y, Laufer N,Eliakim M,Prolactin and liver diseases. Harefuah, 1979, 96: 352-353. |
